pfizer news - Search News

Pfizer, Starboard

Pfizer fight with Starboard heats up, hedge fund alleges executive pressure

The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate actions by its board, after two former executives backed out of its campaign against the company.

MarketWatch on MSN · 2d

Pfizer’s stock dips after two former execs say they won’t support Starboard

Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current management.

Bloomberg on MSN · 2d

Pfizer’s Ex-CEO Won’t Be Involved in Starboard Value Effort

Former Pfizer Inc. executives Ian Read and Frank D’Amelio have decided “not to be involved” in Starboard Value’s activist campaign against the drug company, according to a statement released on their behalf late Wednesday.

Pfizer, FDA and hemophilia B

The Wall Street Journal on MSN · 1d

Pfizer’s Hympavzi Approved for Treatment of Certain Types of Hemophilia

The FDA approved Pfizer’s Hympavzi, which can be an alternative to intravenous infusions often administered multiple times a week.

FiercePharma · 1d

Pfizer doubles down with its 2nd FDA hemophilia approval in 6 months

Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pf | For the second time in six months, the FDA approved a Pfizer treatment for hemophilia. On Friday the U.S. regulator signed off on Hympavzi,

MarketWatch on MSN · 1d

Pfizer wins FDA approval for hemophilia B drug that will be first once-weekly treatment

42m

Pfizer Fizzes Out: From Pandemic Pandemonium To Stunted Growth

Apart from mistrust in the larger pharmaceutical world and Pfizer's inability to find a major break after the pandemic ...

1d

An Activist Investor Just Bought $1 Billion Worth of Pfizer. Here's What It Means for the Stock

On Oct. 6, The Wall Street Journal reported that activist investor group Starboard Value owns a stake in Pfizer ( PFE -0.61%) ...

Pharmalittle: We’re reading about alleged Pfizer threats, industry payments to peer reviewers, and more

Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...

2don MSN

Pfizer's cancer drug combo improves overall survival in late-stage study

Pfizer said on Thursday a combination of its drugs, Talzenna and Xtandi, helped prolong the lives of patients with a type of ...

StockWatch: Investors Unfazed by Illumina’s MiSeq Product Launches, Starboard’s $1B Stake in Pfizer

Investors shrugged as Illumina pressed its case for building on its longtime leadership in next-generation sequencing, ...

A crack of light for Pfizer

Pfizer shared that the combination of its drugs Talzenna and Xtandi extended survival in men with metastatic ...

Pfizer targets broad Talzenna approval in prostate cancer as trial meets patient survival goal

In prostate cancer, Pfizer’s Talzenna already holds the broadest FDA approval within the PARP inhibitor class. | In prostate ...

2don MSNOpinion

Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis

Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results